Literature DB >> 32965653

Behavioral Problems, Quality of Life and Caregiver Burden in Children with Idiopathic Nephrotic Syndrome: Improving Outcomes by Pragmatic Interventions in a Resource-Poor Setting.

Janaki Menon1, Nithya Thuruthiyath2, Anugraha Kannankulangara2, Rohini Kolady3.   

Abstract

A cross-sectional questionnaire-based study was conducted on 38 children with idiopathic nephrotic syndrome. The prevalence and pattern of behavioral abnormalities was studied. Except in the conduct domain, the prevalence of behavioral problems was comparable with controls. Severe complications of disease and adverse drug effects were significantly associated with abnormal behavior. The Quality of life (QOL) of these children and their caregivers was assessed. It appeared to be unaffected by illness. Additional findings were high maternal literacy, no disruption of schooling, regular follow-up and good adherence to treatment. Behavioral problems in childhood nephrotic syndrome can be minimized by regular follow-up and supportive interventions to reduce caregiver burden. Such children and their caregivers can do well in terms of QOL, even in a resource-poor setting, with appropriate psycho-social support.

Entities:  

Keywords:  Behavioral problems; Caregiver burden; Childhood nephrotic syndrome; Improving outcomes; Quality of life; Resource-poor setting

Mesh:

Year:  2020        PMID: 32965653     DOI: 10.1007/s12098-020-03494-7

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  3 in total

1.  Cell-based therapies for amyotrophic lateral sclerosis/motor neuron disease.

Authors:  S Fadilah Abdul Wahid; Zhe Kang Law; Nor Azimah Ismail; Nai Ming Lai
Journal:  Cochrane Database Syst Rev       Date:  2019-12-19

2.  Behavior problems in nephrotic syndrome.

Authors:  M Mehta; A Bagga; P Pande; G Bajaj; R N Srivastava
Journal:  Indian Pediatr       Date:  1995-12       Impact factor: 1.411

Review 3.  Nephrotic syndrome in children.

Authors:  Arvind Bagga; Mukta Mantan
Journal:  Indian J Med Res       Date:  2005-07       Impact factor: 2.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.